3mensio Medical Imaging BV has announced that the company received US Food and Drug Administration (FDA) 510(k) clearance to market the 3surgery Vascular Imaging (VI) software.

This software provides a clinical application for (vascular) surgeons using CTA or MRA studies to determine abnormalities of the vessels within thorax or abdomen, both in 2D and 3D. 3surgery VI provides valuable tools for stent and graft planning of endovascular procedures.

TrackBack URI for this entry

Comments (0)

Subscribe to this comment's feed